Navigation Links
Drug Firm on the Threshold of Developing Dengue Vaccine

A giant pharmaceutical firm is close to developing the world's first vaccine against dengue fever as Singapore and neighbouring countries battle outbreaks, a news report said Friday.

Clinical tests on up to 3,000 people will begin by early next year in Thailand, said Jean Stephenne, GlaxoSmithKline Biologicals president.

"We've been working on the dengue vaccine with the US Army for 10 years, more or less," The Straits Times quoted Stephenne as saying.

The Thai trials will be part of the second phase of the process.

The vaccine was tested on 500 people in the United States during the first phase and proved safe and effective, Stephenne said. Once the Thai trials are completed, the vaccine will move to the final stage to test its effectiveness in other parts of the world, including Singapore.

Cases of the Aedes mosquito-carried virus have reached epidemic levels twice in the city-state since June. There have been 3,597 cases and three deaths since the start of the year.

Intermittent rain and warm weather have been blamed for the onslaught of mosquito breeding.

Stephenne said that another key factor is that the virus has four variations.

"We have to prove the vaccine will be safe for everyone, which means both children and adults," Stephenne told the newspaper.

The company is aiming to have the vaccine on the market in about five years. By that time, Stephenne estimates that between $500 million to $1 billion will have been spent on research and development.


'"/>




Page: 1

Related medicine news :

1. Calcium Supplements May Not Be Useful After A Certain Threshold Is Achieved
2. Risk Of Developing Arthritis
3. Developing HIV fighter
4. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
5. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
6. Men Who at Risk Of Developing Prostate Cancer
7. Identifying The Risks Of Developing Schizophrenia
8. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis
9. Cancer Patients At A Greater Risk Of Developing Blood Clots
10. Young Smokers at Increased Risk Of Developing a Heart Attack
11. Women With Diabetes At Increased Risk Of Developing Cognitive Impairment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... ... 2017 , ... "ProDOF is the perfect set of tools for video editors that want to ... said Christina Austin - CEO of Pixel Film Studios. , Video editors using ProDOF ... of a DSLR racking focus from one area into the next. ProDOF comes with ...
(Date:1/21/2017)... Rosa, CA (PRWEB) , ... January 21, 2017 ... ... announce that Redwood Family Dermatology has recently joined their multi-specialty medical ... a full range of cosmetic services. , “We’re excited to add this excellent ...
(Date:1/20/2017)... ... ... Spectrum Aquatics Launches New ADA Portable Motion Trek BP 300 Lift. Built for durability, this ... wheels, it can be wheeled out of the way and stored when not in use. ... have transformed the feedback from customers into specific enhancements and created a new product that ...
(Date:1/20/2017)... ... , ... Doctor C LLC, a company based out of Arizona that focuses ... the marketing and distribution of its product, The Right C. , The Right C ... than traditional vitamin C supplements. At the trade show, Doctor C had the opportunity ...
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... highest level of nutritional and bodybuilding supplements, announced it attended the January ECRM trade ... a respected bodybuilder and nutritional scientist who was determined to create a line of ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... -- Entscheidung fällt als Reaktion ... Die internationale humanitäre Stadt soll um knapp 2800 m² erweitert ... Seine Hoheit Scheich Muhammad bin Raschid Al ... Dubai , hat den Auftrag erteilt, ... City IHC) zu verdreifachen, um den Betrieb zur Unterstützung ...
(Date:1/19/2017)... 19, 2017 The global immunomodulators market ... 2025, according to a new study by Grand ... be predominantly driven by high R&D investments employed ... production of new and therapeutically advanced drugs. This ... at an unprecedented rate into the immunomodulators market ...
(Date:1/19/2017)... 19, 2017 The U.S. Food and Drug Administration ... Constipation (CIC) in adult patients. "No one ... said Julie Beitz , M.D., director of the Office ... Evaluation and Research. "With the availability of new therapies, patients ... their condition." ...
Breaking Medicine Technology: